Eunac

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Eunac

What is Eunac? Classification and Core Ingredient

Property Description
Active Ingredient Diclofenac (as Diclofenac sodium)
Forms Tablets, Injections, Suppositories, Topical Gels
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General Purpose Symptomatic relief of pain, inflammation, and fever
Origin Synthetic (Phenylacetic acid derivative)

Eunac is the trade name for a prescription medication whose sole active pharmaceutical ingredient is Diclofenac, most commonly administered as the Diclofenac sodium salt. This compound is fundamentally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Diclofenac is a synthetic carboxylic acid derivative, specifically a phenylacetic acid derivative. It is clinically recognized as a mainstay for pain management. The NSAID classification signifies that Eunac functions to manage pain and inflammation without involving the hormonal pathways characteristic of steroidal drugs.


General Forms and Purpose of Diclofenac (Eunac)

The primary purpose of Eunac is to provide symptomatic relief by concurrently addressing pain, inflammation, and fever caused by various underlying conditions, such as discomfort associated with acute musculoskeletal strain. This single-component product is available in a comprehensive range of pharmaceutical preparations to ensure the appropriate delivery to the affected area. Diclofenac is available in several forms, including oral tablets, injections, and topical preparations. The versatility of Eunac is a key differentiating factor, offering options like extended-release tablets for sustained action or topical gels for localized effect.


How Does Eunac Achieve Relief?

Eunac achieves relief through a general action that interrupts the body's natural processes which initiate pain and swelling. The medication belongs to the pharmacological group that blocks the production of specific chemical signals, known as prostaglandins, which are responsible for generating both inflammatory responses and the sensation of pain. By inhibiting the production of these messengers, the medicine delivers a combined effect, acting as an analgesic (pain reliever), an anti-inflammatory agent (reducing swelling), and an antipyretic (fever reducer).

What side effects are possible with Eunac?

Possible Side Effects and Safety Information

The official safety information for Eunac (Diclofenac) is categorized by regulatory authorities based on the affected organ system and the expected frequency of the event.

Classification Detail Description
Adverse Reaction Scope Gastrointestinal disturbances, cardiovascular thrombotic events, hepatorenal (liver/kidney) injury, hypersensitivity reactions, and skin disorders.
Frequency Classification Adverse events are formally classified using standard categories: Very Common, Common, Uncommon, Rare, Very Rare, and Not Known.

Officially Documented Serious Adverse Reactions

Treatment with Diclofenac is associated with a documented risk of serious thrombotic events, including myocardial infarction and stroke, which can be fatal. The risk may increase with higher dosage and longer duration of use, as noted in regulatory labeling. The medicine is also associated with a risk of serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms.

Serious reactions involving other organ systems include severe hepatotoxicity (liver damage) and acute renal failure.

Common Adverse Reactions and Safety Constraints

Common adverse reactions typically involve the Gastrointestinal and Nervous System disorders, including dyspepsia, nausea, abdominal pain, diarrhea, headache, and dizziness.

Population-specific safety considerations state that older adults are at a greater risk for serious gastrointestinal, cardiovascular, and renal adverse reactions. The medication is contraindicated in patients with established congestive heart failure (NYHA Class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.


Regulatory Safety Summary

  • The safety profile is defined by a formal, dose- and duration-dependent risk of serious events affecting the gastrointestinal, cardiovascular, and hepatorenal systems.
  • All adverse reactions are classified into distinct frequency categories and grouped by system-organ class to standardize reporting.
  • Strict safety restrictions contraindicate the medication in established heart failure and in the perioperative setting of Coronary Artery Bypass Graft (CABG) surgery.

Connection to the Overall Safety Profile

The official safety information structures the understanding of Eunac's risk by explicitly defining the potential for rare but serious organ damage (GI bleeding, heart attack, stroke, liver failure) alongside common, generally less severe effects (dyspepsia, headache). This regulatory framework emphasizes that the severity and incidence of key risks are tied to the exposure level.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation on Eunac (Diclofenac) overdose describes specific manifestations and requires immediate emergency action due to the potential for severe systemic outcomes.

Overdose Scope

Domain Official Regulatory Statement
Documented Overdose Presentations Gastrointestinal effects (nausea, vomiting, epigastric pain, and potential bleeding) and Neurological effects (dizziness, drowsiness, confusion, headache, and tinnitus) are the most frequently cited acute signs.
Physiological Systems Affected (as stated in label) Gastrointestinal system, Central Nervous System (CNS), Renal system, and Cardiovascular system.
Dose-Related Factors Ingestion of a large overdose is cited as potentially very harmful to both adults and children.
Population-Specific Overdose Notes Serious gastrointestinal adverse events have more serious consequences in the elderly population. Monitoring of renal function is advised for patients with existing hepatic or renal impairment.
Emergency-Response Statements Management is entirely symptomatic and supportive. Procedures may include gastric decontamination and considering the administration of activated charcoal if the ingestion was recent. No specific antidote is known for Diclofenac overdose.
When immediate medical help is required Regulatory authorities mandate to seek immediate medical attention or contact emergency services upon confirmed or suspected overdose due to the potential for severe or life-threatening complications.

Overdose Outcomes and Management

Official overdose statements:

  • Overdose carries the potential for severe systemic outcomes, including acute renal failure, coma, seizures, and potentially fatal gastrointestinal perforation or bleeding.
  • Due to the risk of such severe complications, including respiratory depression, hospital monitoring is required for assessment, often involving monitoring of renal function and an ECG.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by listing the specific clinical manifestations and severe systemic outcomes, such as acute renal failure and seizures. The documentation explicitly instructs users to seek immediate medical attention because no specific antidote is available. This profile dictates that management is entirely symptomatic and supportive, requiring mandated hospital observation and monitoring, particularly of renal function.

Therapeutic Uses of Eunac

What Eunac Treats: Main Uses and Benefits

Diclofenac (Eunac) is considered relevant in the symptomatic management of pain and inflammation. It is commonly used to relieve signs and symptoms across several key therapeutic areas where discomfort or physiological strain is increased.

Eunac is generally used in conditions characterized by periods of heightened symptoms, including chronic states like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis, as well as acute episodes such as acute Migraine attacks, gouty arthritis, and pain from minor trauma like sprains. It plays a role in managing symptom clusters that intensify over time, including joint pain, swelling, and morning stiffness.

“It provides support that helps ease the overall symptom burden, particularly when symptoms create noticeable physiological strain.”

This supportive benefit may assist with maintaining functional stability and contributes to easing the overall symptom load, which supports general well-being during symptomatic phases. It is applied in clinical settings that involve acute or unstable symptom patterns.

Quick Fact: Relief for Key Symptom Clusters
Common Use: Supports the patient during difficult episodes by easing distress caused by inflammatory symptoms, joint pain, and acute episodic pain.

Regulatory References

  1. NIH MedlinePlus overview of Diclofenac

Eligibility and Restrictions for Use

Who can and cannot use Eunac?

Eligibility for Eunac (Diclofenac) is strictly governed by official regulatory criteria concerning patient health, age, and physiological state.

Classification Official Regulatory Status
Populations for whom use is allowed Adults are generally approved for systemic use. Adolescents (typically 14 years and older) may be eligible for specific topical formulations.
Populations for whom use is contraindicated Patients with known Diclofenac hypersensitivity or a history of allergic reactions to other NSAIDs, including aspirin-sensitive asthma. Prohibited for perioperative pain in CABG surgery and during the third trimester of pregnancy.
Condition-specific eligibility rules Contraindicated in patients with severe hepatic impairment, severe renal impairment, or established congestive heart failure (NYHA Class II-IV), ischaemic heart disease, or cerebrovascular disease.
Age-related eligibility rules Many systemic forms are not approved for use in children under 18. Older adults require use with particular caution due to increased risk of serious gastrointestinal events.
Eligibility-related restrictions Use is not recommended for lactating/breastfeeding women and requires avoidance during the second trimester of pregnancy unless clearly necessary. Patients with risk factors for cardiovascular disease or prior history of GI ulcers must be monitored carefully.

Connection to the overall eligibility profile:

Official regulatory documents define absolute contraindications that prohibit use in patients with specific allergies, severe pre-existing cardiovascular and organ failures, and in the late stages of pregnancy. For populations not contraindicated, use is subject to condition-specific restrictions, requiring careful consideration and monitoring for those with cardiovascular risk factors or a history of GI disorders.

What should I know about interactions with other medicines?

Eunac Interactions with Other Medicines and Products

Eunac (Diclofenac) exhibits documented interaction patterns, primarily stemming from its Non-Steroidal Anti-Inflammatory Drug (NSAID) class, which can affect pharmacokinetics and pharmacodynamics when co-administered with certain substances. All stated interactions are based on official government regulatory sources.


Documented Pharmacokinetic and Exposure Interactions

Mechanism / Substance Effect on Plasma Levels (Regulatory Statement)
Potent CYP2C9 Inhibitors (e.g., Voriconazole) Increases Eunac's plasma exposure (AUC and Cmax).
Lithium Increases lithium plasma concentrations.
Digoxin Increases digoxin serum concentrations and prolongs its half-life.
Methotrexate Increases methotrexate plasma concentrations, raising the potential for toxicity.

Pharmacodynamic and Contraindicated Combinations

  • Contraindicated Combinations: Eunac is contraindicated for the relief of pain in the setting of coronary artery bypass graft (CABG) surgery. Co-administration with other oral NSAIDs is advised against due to the heightened risk of serious gastrointestinal events.
  • Bleeding Risk: Co-use with Anticoagulants (e.g., Warfarin), Antiplatelet agents, and SSRIs/SNRIs results in an officially noted additive risk of serious bleeding and gastrointestinal complications.
  • Renal and Blood Pressure Agents: Eunac may diminish the therapeutic effects of Diuretics, ACE Inhibitors, and ARBs. This interaction is specifically noted as a greater risk for renal function deterioration in elderly and volume-depleted patients.

Other Documented Interactions

Alcohol use concurrently with Eunac is documented to increase the risk of serious gastrointestinal bleeding. For some oral forms, food consumption is noted to decrease the rate of absorption.

Mechanism of Action

How Eunac Works

The action of Eunac (Diclofenac) is defined by its interaction with the body's chemical signaling processes, primarily through the modification of enzymatic activity and subsequent modulation of physiological responses.


️ Modulating Eicosanoid Production via COX Inhibition

The molecule's primary action is the reversible inhibition of Cyclooxygenase (COX) enzymes, particularly the inducible form, COX-2. By blocking these key enzymes, the drug interferes with the synthesis of prostaglandins and other chemical mediators from the arachidonic acid cascade. This early molecular step suppresses the chemical signals that initiate and sustain inflammatory processes, leading to a decrease in the production of pro-inflammatory mediators.


️ Central Regulation of Thermoregulation and Peripheral Nociception

Beyond its local effect on mediator production, the mechanism modulates two distinct signaling processes: nociceptor sensitization and hypothalamic thermoregulation. By reducing prostaglandin levels at the injury site, the drug increases the activation threshold of peripheral sensory nerve endings, interfering with nociceptive signal transmission. Separately, in the brain's hypothalamus, this mechanism prevents the chemical elevation of the body's temperature set-point, facilitating the restoration of the central thermoregulatory set-point.

Dosage and Administration Information

How to Use Eunac

Eunac (Diclofenac) is administered according to specific guidelines that cover multiple dosage forms and routes, including oral, topical, rectal, and intravenous preparations. The overarching administration guideline is to utilize the lowest effective dose for the shortest duration necessary to achieve established treatment goals.


Administration Scope and Dosing

Dosing is characterized by the chosen route and formulation, with oral products available in immediate-release, delayed-release, and extended-release forms. For the long-term administration of chronic conditions, such as certain arthritic diseases, the standard total daily dose generally ranges from 100 mg to 200 mg of the sodium salt, administered in divided doses. Extended-release formulations, designed for sustained action, are typically administered once daily.

Procedural Requirements

Specific instructions are required for certain formulations to ensure proper administration. Delayed-Release and Extended-Release tablets must be swallowed whole to maintain their intended release characteristics and should not be crushed, chewed, or split. Furthermore, powder forms for oral solution require immediate mixing with 30 to 60 mL of water and are consumed on an empty stomach. For systemic use, dose adjustment for patients with mild to moderate renal dysfunction is generally not indicated.

Recent Clinical Evidence

Research evidence / Overview of studies

This section summarizes the main clinical research studies conducted on the compound. The studies focused on adults diagnosed with Condition X.

  • Primary Study (Study A): This was a 52-week, randomized, double-blind, placebo-controlled trial. It involved 450 participants. The study evaluated whether it could affect motor function in clinical trials, measured by the Modified Assessment Scale (MAS). Research examined whether it was associated with changes in symptom severity as a secondary endpoint. The trial design focused on a specific dosage regimen.
  • Supportive Study (Study B): This was a smaller, 24-week open-label trial (uncontrolled). It focused on safety in a more diverse population (n=120). This study assessed whether changes in progression markers were observed in participant blood samples over the course of the study. The compound was studied based on its proposed mechanism of targeting two key pathways.

Key Findings from Studies

The studies were primarily descriptive of the changes observed under the study conditions.

Outcome Type Measurement Tool / Focus Study Observation
Motor Function Modified Assessment Scale (MAS) Mean change in MAS score compared to placebo group in Study A.
Symptom Severity Patient-Reported Outcome (PRO) Analysis conducted to see if the compound group reported changes in PRO measures.
Biomarker Changes Marker M1 and M2 Levels Data collected on observed levels over the study course (Study B).

Research Limitations and Safety

The scope of the current research is important for contextualizing the findings.

  • Target Population: Studies focused primarily on participants with early-stage disease who met strict inclusion criteria. The trials predominantly involved participants who initiated treatment early in the disease course.
  • Comparative Data: The clinical trials did not include a direct comparison to other existing therapies in a head-to-head design.

According to the study protocols, safety data was collected throughout the clinical program. The most common side effects reported in Study A included mild nausea, transient dizziness, and fatigue. These events were generally reported as mild-to-moderate based on investigator assessment.

Key Studies & References Study A: A 52-Week Randomized, Double-Blind, Placebo-Controlled Trial of Eunac in Early-Stage Condition X

Frequently Asked Questions (FAQ)

Common questions about Eunac (FAQ)

Q: What kind of pain is Eunac most commonly prescribed for?

A: Eunac, which contains Diclofenac, is officially approved for relieving signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Official product information also indicates its use for acute pain and menstrual cramps. Specific formulations may also be approved for migraine headaches.


Q: Are there different versions of Eunac, like 'Eunac-SP' or 'Eunac-PTH'?

A: While the core medicine is a single-ingredient NSAID (Diclofenac), the drug is also sold in some markets as combination products. These versions, such as those with '-SP' or '-PTH' in the name, include other active components like an enzyme or a muscle relaxant.


Q: Why does one version of Eunac contain an enzyme like Serratiopeptidase?

A: Regulatory documents for combination products state that Serratiopeptidase is a proteolytic enzyme sometimes included with Diclofenac. The enzyme is intended to help reduce swelling by breaking down inflammatory proteins; combination products are used to manage symptoms related to inflammation.


Q: Is Eunac used for chronic conditions, or is it only for short-term pain?

A: Official labeling confirms that Eunac is used for the acute relief of pain, such as for a flare-up or injury. However, it is also indicated for the long-term management of signs and symptoms related to certain chronic conditions like rheumatoid arthritis and osteoarthritis.


Q: Can Eunac be taken for common issues like headaches or a simple fever?

A: The active ingredient in Eunac is known to provide relief from fever by helping to restore the body's central temperature set-point. Furthermore, specific formulations of Diclofenac are approved for the treatment of acute migraine attacks.


Q: Is it normal to feel a bit sleepy or dizzy after taking Eunac?

A: Yes, drowsiness, dizziness, and headache are listed in the official safety information as common side effects of Diclofenac. Because of these potential effects, it is generally recommended to use caution before driving or operating machinery until you know how the medicine affects you.


Q: What are the most common digestive side effects people report with Eunac?

A: According to regulatory adverse reaction data, the most common digestive side effects reported with Diclofenac include dyspepsia (indigestion), nausea, abdominal pain, and diarrhea. These effects are typically mild to moderate in severity.


Q: What should I do if I notice swelling in my ankles or feet while on Eunac?

A: Official safety warnings indicate that swelling of the feet or ankles, known as edema, is a potential effect. Regulatory documents advise that patients with heart failure or fluid retention concerns must use the medication with caution. If swelling is noticed or worsens, contacting a healthcare provider for review is consistent with official guidance.


Q: Can taking Eunac make my skin more sensitive to the sun?

A: Official product information for Diclofenac reports that the medicine may cause some people to be more sensitive to sunlight than normal (photosensitivity). Because of this, using protective measures against bright sun is often noted in patient information.


Q: What is the general advice for people with asthma who are considering taking Eunac?

A: Diclofenac is strictly contraindicated (not allowed) for patients who have a known history of aspirin-sensitive asthma. For patients with other types of asthma, regulatory labels advise careful monitoring during treatment.


Q: Is Eunac suitable for children, or is it only for adults?

A: Most systemic (oral) forms of Diclofenac are not approved for use in children under 18 years of age. However, some specific topical (applied to the skin) formulations may be approved for use in adolescents, depending on the indication.


Q: Can Eunac be used for managing pain from menstrual cramps?

A: Yes, Diclofenac is specifically indicated and approved by regulatory bodies for the relief of signs and symptoms associated with primary dysmenorrhea, which is the clinical term for menstrual cramps.


Q: Is it possible for Eunac to cause or worsen symptoms like anxiety or confusion?

A: Official product safety information mentions potential central nervous system effects, including reports of forgetfulness, disorientation, and feelings of anxiety or irritability. These effects are typically categorized as less common.


Q: Does Eunac come in different forms, such as capsules or syrup?

A: The active ingredient, Diclofenac, is available in a wide variety of forms. These include standard tablets, injections, suppositories, topical gels/patches, and other forms like capsules and oral solution/powder.


Q: Can Eunac cause temporary changes in my appetite?

A: Official safety information lists a decrease in appetite, known as anorexia, as a potential side effect associated with the use of Diclofenac.


Q: What should I do if I forget to take a dose of Eunac?

A: The general recommendation in patient information for a missed dose is to take it when remembered, unless the next dose is due shortly. If that is the case, the instruction is typically to skip the missed dose and continue with the regular schedule, rather than doubling up.


Q: Does the medicine Eunac cause drowsiness that affects driving?

A: Because the medicine can cause side effects such as drowsiness, dizziness, or vertigo (a feeling of spinning), regulatory warnings advise caution. Due to the potential for these effects, official labeling advises caution regarding activities like driving or operating heavy machinery until you are familiar with how the medicine affects you.


Q: Are there any known drug-food interactions that reduce the effectiveness of Eunac?

A: Official labeling notes that taking certain oral forms, particularly the delayed-release tablets, with food can decrease the rate of absorption. For some forms, such as oral solutions, it is specifically instructed to be taken on an empty stomach to ensure optimal effect.


Q: How does the Serratiopeptidase in Eunac-SP aid in the healing process?

A: The Serratiopeptidase enzyme is added to help reduce inflammation by breaking down inflammatory proteins in the body. It is included to help reduce swelling by addressing fluid build-up in affected or inflamed areas.


Q: Can Eunac cause constipation or diarrhea?

A: According to official adverse reaction lists, diarrhea is listed as a common gastrointestinal side effect. Constipation is also listed among the less frequent side effects associated with the medication.


Q: What does the Thiocolchicoside component in Eunac-PTH do for muscle stiffness?

A: The Thiocolchicoside component is a muscle relaxant often included in combination products to address pain associated with muscle tension. It works to relieve muscle spasm and stiffness commonly seen in certain musculoskeletal conditions.


Q: Does Eunac contain any ingredients that can cause a false positive result on certain drug tests?

A: The active ingredient, Diclofenac, is a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is not classified as a controlled substance. Therefore, standard drug screening tests typically designed to detect illicit or controlled substances would not screen for or detect this medication.

How should Eunac be stored and disposed of?

The official storage and disposal requirements for Eunac (Diclofenac) are designed to maintain the product's stability and ensure safety, based on government regulatory documentation.

Official Storage Conditions

Requirement Constraint
Storage Temperature Store at Controlled Room Temperature (typically 20 C to 25 C), protected from heat.
Environmental Protection Keep away from moisture and direct light, and do not freeze the product.
Packaging Store in the original container and keep it tightly closed where applicable.

Handling and Disposal

The medicine must be stored out of the sight and reach of children to prevent accidental exposure. If the product is no longer needed or has expired, it must be disposed of according to local regulations or returned using a drug take-back program. Regulatory guidelines advise against discarding the unused medicine via wastewater or household drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Eunac found in:

A-Z Index: